Wednesday, August 07, 2013 12:11:48 AM
revenues totaled $451,000 for the second quarter compared to $599,000 for the second quarter
R&D expenses increased to 7.1 million for the second quarter from 4.5 million for the comparable quarter of 2012
http://www.earningsimpact.com/Transcript/82655/ACAD/Q2-2013-Earnings-Call
Recent ACAD News
- Acadia Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025 • Business Wire • 12/19/2024 09:05:00 PM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 12/16/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2024 09:22:29 PM
- Acadia Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million • Business Wire • 12/11/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2024 11:33:31 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/10/2024 11:31:19 PM
- Acadia Pharmaceuticals Appoints Thomas Garner Chief Commercial Officer • Business Wire • 12/09/2024 02:00:00 PM
- Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711 • Business Wire • 11/26/2024 09:05:00 PM
- Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences • Business Wire • 11/21/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2024 09:30:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/20/2024 01:43:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/20/2024 01:41:52 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/20/2024 01:40:08 AM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 11/15/2024 09:05:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 11:48:52 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2024 09:14:26 PM
- Acadia Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operating Overview • Business Wire • 11/06/2024 09:05:00 PM
- Acadia Pharmaceuticals Enters Into an Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 Million • Business Wire • 11/05/2024 09:05:00 PM
- Acadia Pharmaceuticals to Announce Third Quarter Financial Results on November 6, 2024 • Business Wire • 10/17/2024 10:41:00 PM
- Acadia Pharmaceuticals annonce l’approbation de DAYBUE™ (trofinétide) par Santé Canada pour le traitement du syndrome de Rett • Business Wire • 10/16/2024 08:07:00 PM
- Acadia Pharmaceuticals Announces Health Canada Approval of DAYBUE™ (trofinetide) for the Treatment of Rett Syndrome • Business Wire • 10/16/2024 08:07:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/15/2024 10:05:05 PM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 10/08/2024 08:05:00 PM
- Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 09/26/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/25/2024 10:53:04 PM
Hertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing • HZLIF • Dec 20, 2024 9:00 AM
North Bay Resources Announces Arrival of 42 Tons Gold Ore at Bishop Gold Mill, California • NBRI • Dec 20, 2024 9:00 AM
Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives • CAFI • Dec 20, 2024 9:00 AM
$ASNS - Is this the Next Big Cybersecurity Stock? How Actelis Networks is Revolutionizing Critical Infrastructure Protection • ASNS • Dec 20, 2024 8:50 AM
UAV Corp's (UMAV), Skyborne Technology to Build "SKY" Hangar at Its Costin Airport Scheduled for Groundbreaking Ceremony Winter 2025 • UMAV • Dec 20, 2024 8:30 AM
UAV Corp. (UMAV) Reduces Authorized Shares by 1.2 Billion, Demonstrating Commitment to Shareholders; New Authorized Share Count Approved at 800 Million • UMAV • Dec 17, 2024 12:00 PM